Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance
Crossref DOI link: https://doi.org/10.1038/oncsis.2014.37
Published Online: 2014-10-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Truitt, L
Hutchinson, C
DeCoteau, J F
Geyer, C R
Text and Data Mining valid from 2014-10-20
Version of Record valid from 2014-10-20
Article History
Received: 4 July 2014
Revised: 2 September 2014
Accepted: 9 September 2014
First Online: 20 October 2014
Competing interests
: The authors declare no conflict of interest.